References to Primary Literature
- VENDER JR, NAIR SN, LEHMAN JC: NMDA receptors: the first decade. Exp. Opin. Invest. Drugs (1994) 3(4):341–354.
- JJ KULAGOWSKI, PD LEESON: Glycine-site NMDA recep-tor antagonists. Exp. Opin. Ther. Patents (1995) 10(4):1061–1075.
- MCNAMARA JO: Exitatory amino acid receptors and epilepsy. Curt-. Opin. Neurol. Neurasurg. (1993) 6:583–587.
- SAGRATELLA S: NMDA antagonists: anti-epileptic-neuroprotective drugs with diversified neuropharma-cological profiles. Pharmacol. Res. (1995) 32(1/2) 1–13.
- Astra to strengthen R&D, highlights CNS. SCRIP (1995)2079:8.
- SCRIP (1994) 1905:11.
- SCRIP (1994) 1915:13.
- SCRIP (1995) 2019:19.
- SCRIP (1995) 1992:15.
- SCRIP (1995) 2066:11.
- SCRIP (1995) 1996:13.
- SCRIP (1995) 2040:9.
- SCRIP (1995) 2086:25.
- FISONS PLC., EP-279937 (1988).
- SYNTHELABO, EP-428438 (1991).
- UNN. OREGON, W09112797 (1991).
- SANDOZ, DE-3804936 (1988).
- CIBA-GEIGY, EP-203891 (1986).